Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice

✍ Scribed by Maria V. Papadopoulou; Ming Ji; Xinhai Ji; William D. Bloomer; Melinda G. Hollingshead

• Publisher: Springer
• Year: 2002
• Tongue: English
• Weight: 313 KB
• Volume: 50
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-002-0521-8